Inaktiver Wert

Andere Sprachen Ibere Pharmaceuticals

Aktien

Ibere Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
Ibere Pharmaceuticals Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12.08.22
Ibere Pharmaceuticals Reports Earnings Results for the First Quarter Ended March 31, 2022	16.05.22
Ibere Pharmaceuticals Reports Earnings Results for the Full Year Ended December 31, 2021	31.03.22
Ibere Pharmaceuticals Auditor Raises 'Going Concern' Doubt	31.03.22
Ibere Pharmaceuticals Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12.11.21
Certain Class B Ordinary Shares of Ibere Pharmaceuticals are subject to a Lock-Up Agreement Ending on 24-AUG-2021.	24.08.21
Ibere Pharmaceuticals Reports Earnings Results for the Second Quarter Ended June 30, 2021	16.08.21
Ibere Pharmaceuticals : Letter dated August 4, 2021 from Marcum LLP (Form 8-K)	04.08.21
Ibere Pharmaceuticals : Receives Expected NYSE Notice Regarding Delayed Quarterly Report	29.05.21
Ibere Pharmaceuticals : Receives Expected NYSE Notice Regarding Delayed Quarterly Report (Form 8-K)	28.05.21
Ibere Pharmaceuticals announced that it has received $4.835 million in funding	02.03.21
Ibere Pharmaceuticals has completed an IPO in the amount of $120 million.	26.02.21
Ibere Pharmaceuticals announced that it expects to receive $4.835 million in funding	25.02.21
Ibere Pharmaceuticals has filed an IPO in the amount of $100 million.	08.02.21

Keine Ergebnisse zu dieser Suche